Mediterranean diet intervention may not improve breast cancer prognosis in high-risk patients

Researchers discuss the results of a randomized controlled trial to explore the impact of diet on breast cancer recurrence.

JAK Inhibitor Preserves Beta-Cell Function in Early Type 1 Diabetes

A Janus kinase (JAK) inhibitor helped preserve beta-cell function in people with recent-onset type 1 diabetes, the phase II BANDIT trial found. Meeting the study’s

December 7, 2023

Vedolizumab Maintenance Safe and Effective for Kids With IBD

Maintenance treatment with vedolizumab (Entyvio) appeared to be safe and effective in children with inflammatory bowel disease (IBD), with greater effectiveness in those with ulcerative

January 11, 2025

Cybin Launches Strategic Clinical Site Partnerships to Support PARADIGM, a Multinational Pivotal Phase 3 Program Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder | Psychedelic Invest

Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry platform company committed to revolutionizing mental healthcare by developing new and innovative

January 17, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.